Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Core Laboratories N.V.

    NYSE: CLB · Real-Time Price · USD
    11.61
    -0.19 (-1.61%)
    At close: Jun 27, 2025, 3:36 PM

    Core Laboratories Statistics

    Share Statistics

    Core Laboratories has 46.88M shares outstanding. The number of shares has increased by -0.16% in one year.

    Shares Outstanding

    n/a
    		 46.88M

    Shares Change (YoY)

    n/a
    		 -0.16%

    Shares Change (QoQ)

    n/a
    		 -0.26%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 46.36M

    Failed to Deliver (FTD) Shares

    n/a
    		 5

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 7.54M, so 16.09% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 7.54M

    Short % of Shares Out

    n/a
    		 16.09%

    Short % of Float

    n/a
    		 42.97%

    Short Ratio (days to cover)

    n/a
    		 21.23

    Valuation Ratios

    The PE ratio is 25.85 and the forward PE ratio is 13.71. Core Laboratories's PEG ratio is -1.7.

    PE Ratio

    n/a
    		 25.85

    Forward PE

    n/a
    		 13.71

    PS Ratio

    n/a
    		 1.55

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 3.22

    P/FCF Ratio

    n/a
    		 18.72

    PEG Ratio

    n/a
    		 -1.7
    Financial Ratio History

    Enterprise Valuation

    Core Laboratories has an Enterprise Value (EV) of 972.77M.

    EV / Sales

    n/a
    		 1.86

    EV / EBITDA

    n/a
    		 13.28

    EV / EBIT

    n/a
    		 17.25

    EV / FCF

    n/a
    		 22.43

    Financial Position

    The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.71.

    Current Ratio

    n/a
    		 2.32

    Quick Ratio

    n/a
    		 1.71

    Debt / Equity

    n/a
    		 0.71

    Debt / EBITDA

    n/a
    		 2.46

    Debt / FCF

    n/a
    		 4.15

    Interest Coverage

    n/a
    		 4.73

    Financial Efficiency

    Return on Equity is 12.46% and Return on Invested Capital is 8.08%.

    Return on Equity

    n/a
    		 12.46%

    Return on Assets

    n/a
    		 5.32%

    Return on Invested Capital

    n/a
    		 8.08%

    Revenue Per Employee

    n/a
    		 $154,072.94

    Profits Per Employee

    n/a
    		 $9,235.29

    Employee Count

    n/a
    		 3,400

    Asset Turnover

    n/a
    		 0.89

    Inventory Turnover

    n/a
    		 7.33

    Taxes

    Income Tax

    n/a
    		 14.03M

    Effective Tax Rate

    n/a
    		 30.54%

    Stock Price Statistics

    The stock price has increased by -40.26% in the last 52 weeks. The beta is 1.41, so Core Laboratories's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.41

    52-Week Price Change

    n/a
    		 -40.26%

    50-Day Moving Average

    n/a
    		 11.71

    200-Day Moving Average

    n/a
    		 16.19

    Relative Strength Index (RSI)

    n/a
    		 50.11

    Average Volume (20 Days)

    n/a
    		 580,879

    Income Statement

    In the last 12 months, Core Laboratories had revenue of 523.85M and earned 31.4M in profits. Earnings per share was 0.67.

    Revenue

    n/a
    		 523.85M

    Gross Profit

    n/a
    		 88.37M

    Operating Income

    n/a
    		 58.56M

    Net Income

    n/a
    		 31.4M

    EBITDA

    n/a
    		 73.27M

    EBIT

    n/a
    		 58.56M

    Earnings Per Share (EPS)

    n/a
    		 0.67
    Full Income Statement

    Balance Sheet

    The company has 19.16M in cash and 180.14M in debt, giving a net cash position of -160.99M.

    Cash & Cash Equivalents

    n/a
    		 19.16M

    Total Debt

    n/a
    		 180.14M

    Net Cash

    n/a
    		 -160.99M

    Retained Earnings

    n/a
    		 n/a

    Total Assets

    n/a
    		 591.52M

    Working Capital

    n/a
    		 125.04M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 56.39M and capital expenditures -13.03M, giving a free cash flow of 43.36M.

    Operating Cash Flow

    n/a
    		 56.39M

    Capital Expenditures

    n/a
    		 -13.03M

    Free Cash Flow

    n/a
    		 43.36M

    FCF Per Share

    n/a
    		 0.92
    Full Cash Flow Statement

    Margins

    Gross margin is 16.87%, with operating and profit margins of 11.18% and 5.99%.

    Gross Margin

    n/a
    		 16.87%

    Operating Margin

    n/a
    		 11.18%

    Pretax Margin

    n/a
    		 8.77%

    Profit Margin

    n/a
    		 5.99%

    EBITDA Margin

    n/a
    		 13.99%

    EBIT Margin

    n/a
    		 11.18%

    FCF Margin

    n/a
    		 8.28%

    Dividends & Yields

    CLB pays an annual dividend of $0.05, which amounts to a dividend yield of 0.33%.

    Dividend Per Share

    n/a
    		 $0.05

    Dividend Yield

    n/a
    		 0.33%

    Dividend Growth (YoY)

    n/a
    		 0%

    Payout Ratio

    n/a
    		 8.47%

    Earnings Yield

    n/a
    		 3.87%

    FCF Yield

    n/a
    		 5.34%
    Dividend Details

    Analyst Forecast

    The average price target for CLB is $15, which is 27% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $15

    Price Target Difference

    n/a
    		 27%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 9

    Graham Upside

    n/a
    		 -23.79%

    Stock Splits

    The last stock split was on Jul 9, 2010. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Jul 9, 2010

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 2.36

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist